НовостиBenzingaJP Morgan Initiates Coverage On Definium Therapeutics with Overweight Rating, Announces Price Target of $84 JP Morgan Initiates Coverage On Definium Therapeutics with Overweight Rating, Announces Price Target of $84 Benzinga 2026.10.09 19:11 (GMT+0) Открыть на Benzinga Другие новости